<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35337673</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>41 Suppl 1</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.</ArticleTitle><Pagination><StartPage>A58</StartPage><EndPage>A69</EndPage><MedlinePgn>A58-A69</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2022.02.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(22)00145-1</ELocationID><Abstract><AbstractText>Concurrent outbreaks of circulating vaccine-derived poliovirus serotypes 1 and 2 (cVDPV1, cVDPV2) were confirmed in the Republic of the Philippines in September 2019 and were subsequently confirmed in Malaysia by early 2020. There is continuous population subgroup movement in specific geographies between the two countries. Outbreak response efforts focused on sequential supplemental immunization activities with monovalent Sabin strain oral poliovirus vaccine type 2 (mOPV2) and bivalent oral poliovirus vaccines (bOPV, containing Sabin strain types 1 and 3) as well as activities to enhance poliovirus surveillance sensitivity to detect virus circulation. A total of six cVDPV1 cases, 13 cVDPV2 cases, and one immunodeficiency-associated vaccine-derived poliovirus type 2 case were detected, and there were 35 cVDPV1 and 31 cVDPV2 isolates from environmental surveillance sewage collection sites. No further cVDPV1 or cVDPV2 have been detected in either country since March 2020. Response efforts in both countries encountered challenges, particularly those caused by the global COVID-19 pandemic. Important lessons were identified and could be useful for other countries that experience outbreaks of concurrent cVDPV serotypes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Snider</LastName><ForeName>Cynthia J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, 1600 Clifton Road, MS H24-2, Atlanta, GA 30329, USA. Electronic address: csnider@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boualam</LastName><ForeName>Liliane</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Electronic address: boualaml@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallis</LastName><ForeName>Graham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland. Electronic address: tallisg@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for the Western Pacific, United Nations Avenue, 1000 Manila, Philippines. Electronic address: takashimay@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abeyasinghe</LastName><ForeName>Rabindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to the Philippines, Building 3, San Lazaro Compound, Rizal Avenue, Santa Cruz, Manila 1003, Philippines. Electronic address: abeyasingher@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Ying-Ru</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, 4th Floor, Prima 8, Block 3508, Jalan, Teknokrat 6, 63000 Cyberjaya, Selangor, Malaysia. Electronic address: loy@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grabovac</LastName><ForeName>Varja</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for the Western Pacific, United Nations Avenue, 1000 Manila, Philippines. Electronic address: grabovacv@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Avagyan</LastName><ForeName>Tigran</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for the Western Pacific, United Nations Avenue, 1000 Manila, Philippines. Electronic address: avagyant@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslam</LastName><ForeName>Syeda Kanwal</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>World Health Organization Regional Office for the Western Pacific, United Nations Avenue, 1000 Manila, Philippines. Electronic address: saslam@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltayeb</LastName><ForeName>Abu Obeida</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>United Nations Children's Fund East Asia and Pacific Regional Office, 19 Pra Athit Rd, Chana Songkhram, Pra Nakhon, Bangkok 10200, Thailand. Electronic address: aeltayeb@unicef.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aung</LastName><ForeName>Khin Devi</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>United Nations Children's Fund East Asia and Pacific Regional Office, 19 Pra Athit Rd, Chana Songkhram, Pra Nakhon, Bangkok 10200, Thailand. Electronic address: kdaung@unicef.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to the Philippines, Building 3, San Lazaro Compound, Rizal Avenue, Santa Cruz, Manila 1003, Philippines. Electronic address: wangxia@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shrestha</LastName><ForeName>Achyut</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to the Philippines, Building 3, San Lazaro Compound, Rizal Avenue, Santa Cruz, Manila 1003, Philippines. Electronic address: shresthaa@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ante-Orozco</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>United Nations Children's Fund Philippines, 14th Floor- North Tower, Rockwell Business Center Sheridan, Sheridan Street Corner United Street, Highway Hills, Mandaluyong City, Philippines, 1550. Electronic address: corozco@unicef.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Maria Wilda T</ForeName><Initials>MWT</Initials><AffiliationInfo><Affiliation>Republic of the Philippines Department of Health, Department of Health San Lazaro Compound, Rizal Ave., Santa Cruz, Manila, Philippines, 1003. Electronic address: mtsilva@doh.gov.ph.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapastora-Sucaldito</LastName><ForeName>Nemia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Republic of the Philippines Department of Health, Department of Health San Lazaro Compound, Rizal Ave., Santa Cruz, Manila, Philippines, 1003. Electronic address: mlsucaldito@doh.gov.ph.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostol</LastName><ForeName>Lea Necitas G</ForeName><Initials>LNG</Initials><AffiliationInfo><Affiliation>Republic of the Philippines Department of Health, Research Institute for Tropical Medicine, 9002 Research Drive, Filinvest Corporate City Alabang, Muntinlupa City, Philippines, 1781.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jikal</LastName><ForeName>Muhammad Bin Hj</ForeName><Initials>MBH</Initials><AffiliationInfo><Affiliation>Sabah State Health Department, Tingkat 3, Rumah Persekutuan, Jalan Mat Salleh, 88590 Kota Kinabalu, Sabah, Malaysia. Electronic address: drmj@moh.gov.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miraj</LastName><ForeName>Waheed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, 4th Floor, Prima 8, Block 3508, Jalan, Teknokrat 6, 63000 Cyberjaya, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lodhi</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to Malaysia, Brunei Darussalam and Singapore, 4th Floor, Prima 8, Block 3508, Jalan, Teknokrat 6, 63000 Cyberjaya, Selangor, Malaysia. Electronic address: lodhif@who.int.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hyung Joon</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>United Nations Children's Fund Malaysia, Menara PJH, Level 10, No. 2, Jalan Tun Abdul Razak, Precinct 2, 62100 Putrajaya, Malaysia. Electronic address: hkim@unicef.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rusli</LastName><ForeName>Norhayati</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Ministry of Health Malaysia, Aras 3, Blok E10, Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Wilayah Persekutuanm Putrajaya, Malaysia. Electronic address: dr_norhayati@moh.gov.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorley</LastName><ForeName>Bruce R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, Victoria, Australia, 3000. Electronic address: bruce.thorley@vidrl.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Victorian Infectious Diseases Reference Laboratory, The Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne, Victoria, Australia, 3000. Electronic address: Matthew.Kaye@vidrl.org.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishimura</LastName><ForeName>Yorihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: ynishi@nih.go.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Minetaro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama-shi, Tokyo 208-0011, Japan. Electronic address: minetaro@nih.go.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sani</LastName><ForeName>Jamiatul Aida Md</ForeName><Initials>JAM</Initials><AffiliationInfo><Affiliation>Ministry of Health Malaysia, Aras 3, Blok E10, Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Wilayah Persekutuanm Putrajaya, Malaysia. Electronic address: jamiatul@moh.gov.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rundi</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sabah State Health Department, Tingkat 3, Rumah Persekutuan, Jalan Mat Salleh, 88590 Kota Kinabalu, Sabah, Malaysia. Electronic address: christinarundi@moh.gov.my.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldon</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Office of the World Health Organization Representative to the Philippines, Building 3, San Lazaro Compound, Rizal Avenue, Santa Cruz, Manila 1003, Philippines.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010679" MajorTopicYN="N" Type="Geographic">Philippines</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Circulating vaccine-derived poliovirus</Keyword><Keyword MajorTopicYN="N">Immunodeficiency-associated vaccine-derived poliovirus</Keyword><Keyword MajorTopicYN="N">Malaysia</Keyword><Keyword MajorTopicYN="N">Philippines</Keyword><Keyword MajorTopicYN="N">Poliovirus outbreak</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35337673</ArticleId><ArticleId IdType="mid">NIHMS1914837</ArticleId><ArticleId IdType="pmc">PMC10546869</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2022.02.022</ArticleId><ArticleId IdType="pii">S0264-410X(22)00145-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anis E, Kopel E, Singer SR, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Euro Surveill 2013;18(38).</Citation><ArticleIdList><ArticleId IdType="pubmed">24084337</ArticleId></ArticleIdList></Reference><Reference><Citation>Arie S Polio virus spreads from Syria to Iraq. BMJ 2014;348(apr02 3):g2481.</Citation><ArticleIdList><ArticleId IdType="pubmed">24696176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Ryan MJ, Smith P, Mahamud A, Farag N, Haithami S, et al. Response to a Large Polio Outbreak in a Setting of Conflict - Middle East, 2013&#x2013;2015. MMWR Morb Mortal Wkly Rep 2017;66(8):227&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5657899</ArticleId><ArticleId IdType="pubmed">28253229</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagan JE, Wassilak SG, Craig AS, et al. Progress toward polio eradication - worldwide, 2014&#x2013;2015. MMWR Morb Mortal Wkly Rep 2015;64(19):527&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584572</ArticleId><ArticleId IdType="pubmed">25996095</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeting of the Strategic Advisory Group of Experts on Immunization. November 2012 &#x2013; conclusions and recommendations. Wkly Epidemiol Rec 2013;88(1):1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">23311010</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R, Kew OM, Cochi SL, Aylward RB. Poliovirus vaccine-live. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 7th ed. Philadelphia, PA: Elsevier, Inc.; 2018. p. 866&#x2013;917.</Citation></Reference><Reference><Citation>Gurung S, Harris JB, Eltayeb AO, Hampton LM, Diorditsa S, Avagyan T, et al. Experience With Inactivated Polio Vaccine Introduction and the &#x201c;Switch&#x201d; From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization&#x2019;s Western Pacific Region. J Infect Dis 2017;216(suppl_1):S101&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853504</ArticleId><ArticleId IdType="pubmed">28838170</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. WHO/UNICEF estimates of national immunization coverage (WUENIC); 2020. https://www.who.int/teams/immunization-vaccines-and-biologicals/data-statistics-and-graphics2020.</Citation></Reference><Reference><Citation>Republic of the Philippines Department of Health. DOH identifies vaccine hesitancy as one of the reasons for measles outbreak; 2019. https://doh.gov.ph/node/16721 [accessed 1 June 2021].</Citation></Reference><Reference><Citation>GPEI . Standard operating procedures: respond to a poliovirus event or outbreak; 2020. http://polioeradication.org/wp-content/uploads/2020/04/POL-SOP-V3.1-20200424.pdf3.1.</Citation></Reference><Reference><Citation>Republic of the Philippines Department of Health. Polio case confirmed in the Philippines: DOH to mount mass immunization campaign; 2019. https://doh.gov.ph/node/18012 [accessed June 1 2021].</Citation></Reference><Reference><Citation>Jorba J, Campagnoli R, De L, Kew O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 2008;82 (9):4429&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2293050</ArticleId><ArticleId IdType="pubmed">18287242</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI. Interim Guidance for the poliomyelitis (polio) surveillance network in the context of coronavirus disease (COVID-19); 2020. http://polioeradication.org/wp-content/uploads/2020/06/Interim-Guidance-Polio-Surveillance-in-the-context-of-COVID19-20200514.pdf [accessed 14 May 2020].</Citation></Reference><Reference><Citation>GPEI. Call to action to support COVID-19 response; 2020. http://polioeradication.org/wp-content/uploads/2020/04/POB-COVID-19-Statement-20200402.pdf [accessed 03 April 2020].</Citation></Reference><Reference><Citation>Bauri M, Wilkinson AL, Ropa B, Feldon K, Snider CJ, Anand A, et al. Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response - Papua New Guinea, 2018. MMWR Morb Mortal Wkly Rep 2019;68(5):119&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366675</ArticleId><ArticleId IdType="pubmed">30730867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Zacar&#x131;&#xe1;s Garib, et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002;296(5566):356&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11896235</ArticleId></ArticleIdList></Reference><Reference><Citation>2020 Environmental Performance Index &#x2013; Sanitation &amp; Drinking Water; 2021. https://epi.yale.edu/epi-results/2020/component/h2o2021.</Citation></Reference><Reference><Citation>WHO. Statement of the Twenty-Third IHR Emergency Committee Regarding the International Spread of Poliovirus; 2020. https://www.who.int/news/item/07-01-2020-statement-o-the-twenty-third-ihr-emergency-committee-regarding-the-international-spread-of-poliovirus [accessed March 25 2021].</Citation></Reference><Reference><Citation>Zhao K, Jorba J, Shaw J, Iber J, Chen Qi, Bullard K, et al. Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs? Comput Struct Biotechnol J 2017;15:456&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5671402</ArticleId><ArticleId IdType="pubmed">29276577</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI. Guidelines for Implementing Poliovirus Surveillance among Patients with Primary Immunodeficiency Disorders (PIDs); 2020. https://polioeradication.org/wp-content/uploads/2020/12/Guidelines-for-Implementing-PID-Suveillance-3.3-20201215.pdf [accessed 3 June 2021].</Citation></Reference><Reference><Citation>Hsu CH, Kader M, Mahamud A, Bullard K, Jorba J, Agbor J, et al. Progress Toward Poliomyelitis Eradication &#x2013; Pakistan, January 2018-September 2019. MMWR Morb Mortal Wkly Rep 2019;68(45):1029&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855509</ArticleId><ArticleId IdType="pubmed">31725710</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C, Alleman MM, Ehrhardt D, Wiesen E, Burns CC, Liu H, et al. Update on vaccine-derived poliovirus outbreaks &#x2013; democratic republic of the Congo and Horn of Africa, 2017&#x2013;2018. MMWR Morb Mortal Wkly Rep 2019;68 (9):225&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421971</ArticleId><ArticleId IdType="pubmed">30845121</ArticleId></ArticleIdList></Reference><Reference><Citation>Agenda Immunization
2030 &#x2013; a global strategy to leave no one behind; 2020. http://www.immunizationagenda2030.org/.</Citation><ArticleIdList><ArticleId IdType="pubmed">39004466</ArticleId></ArticleIdList></Reference><Reference><Citation>GPEI. nOPV2; 2021. https://polioeradication.org/nopv2/ [accessed 12 December 2021].</Citation></Reference><Reference><Citation>Van Damme P, De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, et al. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study. Lancet 2019;394(10193):148&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6626986</ArticleId><ArticleId IdType="pubmed">31174831</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>